Q1 2025 Holdings
Filed 2025-05-14 | 117 holdings | $1.8B | 13F-HR/A | View on SEC ↗ · Holdings Table ↗
Amended (2025-05-23) | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↑ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Avidity Biosciences Inc(RNA) | COM | 05370A108 | $32.8M | 1,110,610 | 1.8% |
| Arrowhead Pharmaceuticals Inc(ARWR) | COM | 04280A100 | $34.0M | 2,669,880 | 1.9% |
| Edgewise Therapeutics Inc(EWTX) | COM | 28036F105 | $37.3M | 1,696,444 | 2.1% |
| NewAmsterdam Pharma Company NV(NAMS) | ORDINARY SHARES | N62509109 | $39.1M | 1,912,030 | 2.2% |
| Centessa Pharmaceuticals PLC(CNTA) | SPONSORED ADS | 152309100 | $42.6M | 2,960,029 | 2.4% |
| Bicara Therapeutics Inc(BCAX) | COM | 055477103 | $42.6M | 3,267,083 | 2.4% |
| Merus NV | COM | N5749R100 | $43.9M | 1,043,467 | 2.5% |
| Ascendis Pharma A/S(ASND) | SPONSORED ADR | 04351P101 | $44.8M | 287,366 | 2.5% |
| Soleno Therapeutics Inc(SLNO) | COM | 834203309 | $52.0M | 727,337 | 2.9% |
| Disc Medicine Inc(IRON) | COM | 254604101 | $53.2M | 1,071,865 | 3.0% |
| Apellis Pharmaceuticals Inc(APLS) | COM | 03753U106 | $56.4M | 2,578,396 | 3.2% |
| Crinetics Pharmaceuticals Inc(CRNX) | COM | 22663K107 | $56.6M | 1,688,611 | 3.2% |
| Blueprint Medicines Corp(2L9) | COM | 09627Y109 | $64.3M | 726,167 | 3.6% |
| Kymera Therapeutics Inc(KYMR) | COM | 501575104 | $88.7M | 3,240,313 | 5.0% |
| Beigene Ltd(ONC) | SPONSORED ADS | 07725L102 | $135.7M | 498,689 | 7.7% |
| Scholar Rock Holding Corp(SRRK) | COM | 80706P103 | $297.4M | 9,250,005 | 16.8% |